SOUTH SAN FRANCISCO, Calif., Oct. 21 /PRNewswire/ -- NGM Biopharmaceuticals, Inc. (NGM), a private company dedicated to the discovery and development of novel biotherapeutics for the treatment of Type 2 diabetes and other metabolic diseases, today announced that Arthur D.

SANTA MONICA, Calif., Oct. 12 /PRNewswire-USNewswire/ -- Arthur D.

SANTA MONICA, Calif., Aug. 3 /PRNewswire-USNewswire/ -- Genentech Board Chairman Arthur D.

-- Roche intends to acquire all outstanding shares of Genentech for US$95.00 per share in cash -- Research and early development to operate as an independent center; South San Francisco site to become headquarters of combined U.S.

By Steve Johnson, San Jose Mercury News, Calif. Jul. 21--In a blockbuster move that could bring an end to the corporate independence of a Bay Area biotechnology legend, Swiss drug giant Roche is proposing to take complete control of South San Francisco-based Genentech for nearly $44 billion.